Jerusalem, Israel

Suher Masri

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suher Masri: Innovator in Gastroretentive Drug Delivery Systems

Introduction

Suher Masri is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. Her innovative approach has led to the development of a unique gastroretentive dosage form that enhances the efficacy of medications.

Latest Patents

Suher Masri holds a patent for a gastroretentive drug delivery system. This system is a biodegradable, multi-layered controlled release dosage form that is designed to improve the delivery of zaleplon. The invention allows for a first dosage of zaleplon to be released in a controlled manner, while a second dosage is released immediately upon contact with gastric juice. This innovative dosage form unfolds rapidly in the stomach and gastrointestinal tract, providing efficient sleep induction with minimal next-day residual effects. She has 1 patent to her name.

Career Highlights

Suher Masri is associated with Intec Pharma Ltd., where she continues to work on advancing drug delivery technologies. Her research focuses on creating effective solutions for patients, particularly in the area of sleep medications. Her work has garnered attention for its potential to improve patient outcomes.

Collaborations

Suher collaborates with notable colleagues, including Eytan Moor and David Kirmayer. Their combined expertise contributes to the innovative projects at Intec Pharma Ltd.

Conclusion

Suher Masri's contributions to the field of gastroretentive drug delivery systems highlight her role as an influential inventor. Her work not only advances pharmaceutical technology but also aims to enhance the quality of life for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…